Fiche centre
Investigational Site Number : 3560009
Nagpur — India
Essais liés2clinical trials
VilleNagpurlocalisation
PaysIndialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04411641
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tolebrutinib | SEP | Phase 3 | NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING |
| Tolebrutinib | SEP | Phase 3 | NCT04411641 | Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) | COMPLETED |